Protective Effects of 6-Gingerol on Cardiotoxicity Induced by Arsenic Trioxide Through AMPK/SIRT1/PGC-1α Signaling

Xue Han1, Yakun Yang1, Muqing Zhang2

  • 1School of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, China.

Insights

6-Gingerol (6G) protects against arsenic trioxide (As2O3)-induced cardiotoxicity by reducing oxidative stress, inflammation, and apoptosis. This protective effect is linked to the activation of the AMPK/SIRT1/PGC-1α signaling pathway.

Area of Science:

  • Pharmacology
  • Cardiology
  • Natural Products Chemistry

Background:

  • Arsenic trioxide (As2O3) is an effective anticancer agent but its clinical use is limited by cardiotoxicity.
  • 6-Gingerol (6G), the primary active compound in ginger, possesses numerous health benefits.
  • Investigating 6G's protective mechanisms against As2O3-induced heart damage is crucial.

Purpose of the Study:

  • To elucidate the pharmacological mechanisms by which 6-Gingerol mitigates arsenic trioxide-induced myocardial injury.
  • To evaluate the efficacy of 6G in preventing As2O3-induced cardiotoxicity in a mouse model.

Main Methods:

  • A mouse model was established using As2O3 to induce cardiotoxicity.
  • Mice were treated with varying doses of 6G or vehicle control.
  • Analyses included biochemical assays, histopathology, electron microscopy, ELISA, and Western blotting to assess cardiac function and molecular pathways.

Main Results:

  • As2O3 administration led to significant cardiotoxicity, evidenced by histopathological damage, oxidative stress, mitochondrial dysfunction, inflammation, and cardiomyocyte apoptosis.
  • 6G treatment markedly ameliorated As2O3-induced cardiac injury and its associated pathological features.
  • 6G reversed the As2O3-induced inhibition of the AMPK/SIRT1/PGC-1α signaling pathway.

Conclusions:

  • 6-Gingerol effectively counteracts arsenic trioxide-induced cardiotoxicity.
  • The protective effects of 6G involve the mitigation of oxidative stress, inflammation, and apoptosis in cardiomyocytes.
  • Activation of the AMPK/SIRT1/PGC-1α signaling pathway is a key mechanism underlying 6G's cardioprotective action.